Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer

Suzanne J Forrest^{1

2}, Hersh Gupta^{3

4}, Abigail Ward⁵, Yvonne Y Li^{3

4}, Duong Doan⁵, Alyaa Al-Ibraheemi^{6

7}, Sanda Alexandrescu^{6

7}, Pratiti Bandopadhayay^{5

6}, Suzanne Shusterman^{5

6}, Elizabeth A Mullen^{5

6}, Natalie B Collins^{5

6}, Susan N Chi^{5

6}, Karen D Wright^{5

6}, Priti Kumari³, Tali Mazor³, Keith L Ligon^{6

3

7

8}, Priyanka Shivdasani⁸, Monica Manam⁷, Laura E MacConaill⁸, Evelina Ceca⁵, Sidney N Benich⁵, Wendy B London⁵, Richard L Schilsky⁹, Suanna S Bruinooge⁹, Jaime M Guidry Auvil¹⁰, Ethan Cerami³, Barrett J Rollins^{6

3

8}, Matthew L Meyerson^{6

3

4}, Neal I Lindeman¹¹, Bruce E Johnson^{6

3

8}, Andrew D Cherniack^{3

4}, Alanna J Church^{6

7}, Katherine A Janeway^{12

13}

Affiliations

¹ Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu.
² Harvard Medical School, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu.
³ Dana-Farber Cancer Institute, Boston, MA, USA.
⁴ Broad Institute of MIT and Harvard, Cambridge, MA, USA.
⁵ Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
⁶ Harvard Medical School, Boston, MA, USA.
⁷ Boston Children's Hospital, Boston, MA, USA.
⁸ Brigham and Women's Hospital, Boston, MA, USA.
⁹ American Society of Clinical Oncology, Alexandria, VA, USA.
¹⁰ National Cancer Institute, Bethesda, MD, USA.
¹¹ Weill Cornell Medical College, New York, NY, USA.
¹² Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.
¹³ Harvard Medical School, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.

Published Erratum

Suzanne J Forrest et al. Nat Commun. 2024.

. 2024 Aug 22;15(1):7218.

doi: 10.1038/s41467-024-51184-1.

¹ Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu.
² Harvard Medical School, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu.
³ Dana-Farber Cancer Institute, Boston, MA, USA.
⁴ Broad Institute of MIT and Harvard, Cambridge, MA, USA.
⁵ Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
⁶ Harvard Medical School, Boston, MA, USA.
⁷ Boston Children's Hospital, Boston, MA, USA.
⁸ Brigham and Women's Hospital, Boston, MA, USA.
⁹ American Society of Clinical Oncology, Alexandria, VA, USA.
¹⁰ National Cancer Institute, Bethesda, MD, USA.
¹¹ Weill Cornell Medical College, New York, NY, USA.
¹² Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.
¹³ Harvard Medical School, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.

No abstract available

Erratum for

Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.
Forrest SJ, Gupta H, Ward A, Li YY, Doan D, Al-Ibraheemi A, Alexandrescu S, Bandopadhayay P, Shusterman S, Mullen EA, Collins NB, Chi SN, Wright KD, Kumari P, Mazor T, Ligon KL, Shivdasani P, Manam M, MacConaill LE, Ceca E, Benich SN, London WB, Schilsky RL, Bruinooge SS, Guidry Auvil JM, Cerami E, Rollins BJ, Meyerson ML, Lindeman NI, Johnson BE, Cherniack AD, Church AJ, Janeway KA. Forrest SJ, et al. Nat Commun. 2024 Jul 11;15(1):5837. doi: 10.1038/s41467-024-49944-0. Nat Commun. 2024. PMID: 38992034 Free PMC article.